Overview
An essential amino acid that is physiologically active in the L-form.
Indication
Used for nutritional supplementation, also for treating dietary shortage or imbalance.
Associated Conditions
- Acromegaly
- Craniopharyngioma
- Disorders of urea cycle metabolism
- Gigantism
- Hyperammonaemia
- Hypophysectomy
- Kidney Damage
- Panhypopituitarism
- Pituitary Dwarfism
- Pituitary Neoplasms
- Pituitary trauma
- Problems of growth and stature
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/07/03 | Not Applicable | Recruiting | General Hospital of Shenyang Military Region | ||
2024/04/03 | Phase 3 | Not yet recruiting | |||
2024/02/29 | Phase 1 | Recruiting | TJ Biopharma Co., Ltd. | ||
2024/02/23 | Phase 1 | Recruiting | Armed Forces Institute of Dentistry, Pakistan | ||
2023/10/06 | Phase 4 | Completed | Beijing Tiantan Hospital | ||
2023/09/22 | Not Applicable | Completed | Geropharm | ||
2023/06/27 | Not Applicable | Recruiting | University of Electronic Science and Technology of China | ||
2023/05/11 | Phase 2 | Recruiting | |||
2022/09/30 | Phase 3 | Completed | |||
2022/06/30 | Phase 4 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Baxter Healthcare Corporation | 0338-0184 | INTRAVENOUS | 920 mg in 100 mL | 4/13/2021 | |
| Baxter Healthcare Company | 0338-0210 | INTRAVENOUS | 920 mg in 100 mL | 9/21/2020 | |
| Baxter Healthcare Corporation | 0338-0210 | INTRAVENOUS | 920 mg in 100 mL | 9/21/2020 | |
| Baxter Healthcare Corporation | 0338-1089 | INTRAVENOUS | 489 mg in 100 mL | 4/13/2021 | |
| Baxter Healthcare Corporation | 0338-1099 | INTRAVENOUS | 575 mg in 100 mL | 4/13/2021 | |
| ICU Medical Inc. | 0990-7171 | INTRAVENOUS | 1527 mg in 100 mL | 5/4/2022 | |
| Baxter Healthcare Corporation | 0338-0194 | INTRAVENOUS | 920 mg in 100 mL | 4/13/2021 | |
| Baxter Healthcare Company | 0338-1147 | INTRAVENOUS | 575 mg in 100 mL | 9/21/2020 | |
| Baxter Healthcare Corporation | 0338-1147 | INTRAVENOUS | 575 mg in 100 mL | 9/21/2020 | |
| Baxter Healthcare Company | 0338-1142 | INTRAVENOUS | 316 mg in 100 mL | 9/21/2020 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| SmofKabiven Emulsion for Infusion | SIN14286P | INJECTION, EMULSION | 12.0g /1000ml | 1/8/2013 | |
| SmofKabiven Electrolyte Free Emulsion for Infusion | SIN14292P | INJECTION, EMULSION | 12.0g /1000ml | 1/16/2013 | |
| NUTRIFLEX® OMEGA PLUS EMULSION FOR INFUSION | SIN15468P | INJECTION, EMULSION | 2.592g/1000ml | 4/23/2018 | |
| PERIOLIMEL N4E Emulsion for Infusion | SIN16888P | EMULSION | 2.48g/L | 10/20/2023 | |
| TROPHAMINE INJECTION 10% | SIN07846P | INJECTION | 1.2 g/100 ml | 9/12/1994 | |
| AMINOPLASMAL B.BRAUN 10% E SOLUTION FOR INFUSION | SIN15411P | INFUSION, SOLUTION | 11.50g/1000ml | 1/23/2018 | |
| SmofKabiven Peripheral Emulsion for Infusion | SIN14287P | INJECTION, EMULSION | 12.0g /1000ml | 1/8/2013 | |
| NUTRIFLEX® OMEGA SPECIAL B. BRAUN EMULSION FOR INFUSION | SIN16734P | INJECTION, EMULSION | 3.780g/1000ml | 3/7/2023 | |
| VAMINOLACT INTRAVENOUS SOLUTION | SIN07428P | INJECTION | 4.1 g/1000 ml | 5/12/1993 | |
| AMINOSTERIL N-HEPA FOR INTRAVENOUS INFUSION 8% | SIN10000P | INJECTION | 10.72 g/l | 9/15/1998 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Arginine Hydrochloride Tablets | 国药准字H20057614 | 化学药品 | 片剂 | 11/15/2019 | |
| Arginine Hydrochloride Tablets | 国药准字H11022102 | 化学药品 | 片剂 | 11/27/2020 | |
| Arginine Hydrochloride Tablets | 国药准字H43021923 | 化学药品 | 片剂 | 11/6/2020 | |
| Arginine Hydrochloride for Injection | 国药准字H20050685 | 化学药品 | 注射剂 | 6/24/2020 | |
| Arginine Hydrochloride for Injection | 国药准字H20051875 | 化学药品 | 注射剂 | 9/2/2020 | |
| Arginine Hydrochloride for Injection | 国药准字H20050686 | 化学药品 | 注射剂 | 6/24/2020 | |
| Arginine Hydrochloride for Injection | 国药准字H20051876 | 化学药品 | 注射剂 | 9/2/2020 | |
| Arginine Hydrochloride for Injection | 国药准字H20052504 | 化学药品 | 注射剂 | 3/9/2020 | |
| Arginine Hydrochloride for Injection | 国药准字H20080593 | 化学药品 | 注射剂 | 12/7/2022 | |
| Arginine Hydrochloride Injection | 国药准字H42023001 | 化学药品 | 注射剂 | 6/10/2022 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| LA-FLAMING INJ. | N/A | N/A | N/A | 1/28/2010 | |
| VAMINOLACT I.V. SOLUTION | N/A | N/A | N/A | 10/14/1992 | |
| OLIMEL N9E EMULSION FOR INFUSION | N/A | N/A | N/A | 10/24/2013 | |
| NUTRIFLEX OMEGA SPECIAL EMULSION FOR INFUSION | N/A | N/A | N/A | 1/11/2012 | |
| SMOFKABIVEN EMULSION FOR INFUSION | N/A | N/A | N/A | 5/26/2011 | |
| PERIOLIMEL N4E EMULSION FOR INFUSION | N/A | N/A | N/A | 10/24/2013 | |
| PAN-AMIN G INJ | N/A | N/A | N/A | 5/17/1979 | |
| PAN-AMIN G SOLUTION FOR INFUSION 500ML | N/A | otsuka pharmaceutical (h.k.) limited | N/A | N/A | 4/5/2012 |
| NUTRIFLEX OMEGA PLUS EMULSION FOR INFUSION | N/A | N/A | N/A | 1/11/2012 | |
| AMINOGEN-S SOLUTION FOR INFUSION | N/A | wings pharmaceutical ltd | N/A | N/A | 8/15/2013 |
TGA Drug Approvals
Help Us Improve
Your feedback helps us provide better drug information and insights.